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Chapter





Legionella pneumophila is one of the important pathogens in community-
acquired (CAP) and hospital-acquired pneumonia that can cause severe pneu-
monia. Early diagnosis and treatment of Legionella pneumonia (LP) are essential 
because inappropriate therapy for Legionella pneumonia has been reported to 
worsen the prognosis. The most frequently identified causative pathogen of 
Legionella pneumonia is Legionella pneumophila serogroup 1. Legionella pneumonia 
due to non-Legionella pneumophila serogroup 1 is seen in 20% of cases. In diagnos-
ing Legionella pneumonia caused by non-Legionella pneumophila serogroup 1, the 
urinary antigen test is usually negative; therefore, we need to suspect Legionella 
pneumonia by clinical information such as symptoms, vital signs, laboratory find-
ings, and radiological findings. Based on our previous report, Legionella pneumonia 
due to non-Legionella pneumophila serogroup 1 was a mild to severe pneumonia. In 
addition, in about half of the patients, we could not suspect Legionella pneumonia 
using a six-point scoring system, which is one of the diagnostic scoring systems. 
Recently, a new urinary antigen test kit that could theoretically diagnose Legionella 
pneumonia due to non-Legionella pneumophila serogroup 1 was released in Japan. 
This can help in early diagnosis of Legionella pneumonia, including the one caused 
by non-Legionella pneumophila serogroup 1.
Keywords: diagnosis, Legionella pneumonia, Legionella pneumophila serogroup 1, 
non-Legionella pneumophila serogroup 1, urinary antigen
1. Introduction
Legionella pneumonia (LP) is caused by Legionella species that are important 
causative pathogens of community-acquired pneumonia (CAP) and hospital-
acquired pneumonia. There are 58 species and three subspecies in the Legionella 
genus [1]. Legionella species are small to filamentous, Gram-negative rods [2].
The most frequently identified causative microorganism of Legionella pneu-
monia is Legionella pneumophila serogroup 1, accounting for about 80% of cases 
[3, 4]. In CAP, the rate of LP is reported to be 0.6–8% [5–8], although the rate 
differs in different areas and countries. However, in severe CAP that satisfies 
the Infectious Diseases Society of America/American Thoracic Society severe 
pneumonia criteria [9], LP is one of the most important etiologies, because the 
rate of LP was reported to be 13.5% in 133 patients [10] and 14.1% in 71 patients 
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<60 years old [11]. In addition, inappropriate initial therapy for LP was shown to 
be one of the independent factors predicting a worse prognosis [12]. Therefore, 
early and appropriate diagnosis of LP is very important to improve the prognosis 
of LP patients.
The gold standard in the diagnosis of LP is the identification of Legionella 
species in respiratory specimens such as sputum and bronchoalveolar lavage 
fluid. However, some LP patients have no sputum for culture, a dedicated culture 
medium, such as Wadowsky-Yee-Okuda-α or Buffered Charcoal Yeast Extract-α 
medium is needed, therefore identification of Legionella species is sometimes dif-
ficult, costly and time-consuming.
Currently, a urinary antigen test that detects soluble antigens is widely used 
for diagnosing LP in daily clinical practice worldwide. This diagnostic method is 
very useful because the examination procedure is simple and the results are known 
quickly. In a systematic review and meta-analysis, Shimada et al. reported that the 
specificity of the Legionella urinary antigen test was 99.1% and sensitivity was 74%; 
therefore, LP cannot be ruled out if this test is negative. Specifically, the sensitivity 
of the urinary antigen test for diagnosing LP due to non-L. pneumophila serogroup 1 
is low [13]. Therefore, the Legionella urinary antigen test is not useful for diagnos-
ing LP caused by non-L. pneumophila serogroup 1.
The diagnostic key for LP due to non-L. pneumophila serogroup 1 is to suspect 
Legionella pneumonia based on clinical information such as patients’ symptoms, 
vital signs, laboratory findings, and radiological findings. Therefore, in this chapter, 
we describe the clinical characteristics of LP due to non-L. pneumophila serogroup 1 
referred to in previous reports.
2. Legionella pneumonia due to non-Legionella pneumophila serogroup 1
2.1 Previous reports
In earlier studies, LP due to non-L. pneumophila serogroup 1 could be a mild to 
moderate pneumonia [14, 15], not only a severe pneumonia admitted to intensive 
care unit [16–20]. Indeed, we reported a case of LP due to L. pneumophila sero-
group 9 in which initial treatment with single-dose oral azithromycin appeared 
useful, although oral levofloxacin was administered subsequently [15].
There have been many case reports of LP caused by non-L. pneumophila 
serogroup 1, but there have been few case series. Therefore, we investigated the 
clinical characteristics of LP due to non-L. pneumophila serogroup 1 and compared 
with LP due to L. pneumophila serogroup 1 [21]. There were 11 patients with LP 
due to non-L. pneumophila serogroup 1 between March 2001 and June 2016 in our 
hospital. Their age range was 58–82 years, and eight patients (72.7%) were male. 
The most common comorbidities were diabetes mellitus, chronic liver disease, and 
malignant disease in each of the two patients. The most common symptom was 
fever (72.7%), followed by cough (54.5%), and sputum (54.5%). The distribution 
of bacterial strains was L. pneumophila serogroup 3 in six patients, L. pneumophila 
serogroup 9 in three patients, L. pneumophila serogroup 6 in one patient, and L. 
longbeachae in one patient. As to the severity of pneumonia, about half of the cases 
(5/11) were mild to moderate according to the pneumonia severity index (PSI) [22], 
whereas most cases (10/11) were mild to moderate based on CURB-65 [23]. Five 
patients whose PSI class was less than IV are all improved with oral azithromycin or 
oral levofloxacin. In contrast, four patients were admitted to the intensive care unit, 
and all four patients were administered appropriate empiric antimicrobial agents, 
but three patients died.
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2.2 Diagnostic scoring system
We cannot rule out LP by a negative result of the urinary antigen test because 
the sensitivity of this test is not very good. To diagnose LP with a negative urinary 
antigen test, we need to suspect it based on the symptoms, vital signs, laboratory 
examinations, and radiological findings.
In 1998, Cunha advocated a diagnostic scoring system for LP called the 
“Winthrop-University Hospital (WUH) criteria” [24]. The WUH criteria comprised 
15 clinical findings and seven laboratory findings, and it was therefore thought to be 
too complicated to use in the daily clinical practice.
In 2009, Fiumefreddo proposed a six-point scoring system for predicting LP 
[25], and this scoring system was validated by Haubitz [26]. This scoring system 
comprised one symptom, one vital sign, and four laboratory findings. The criteria 
for the six items are listed in Table 1. A score ≥5 had very high specificity (99.0%) 
and a high positive predictive value (17.4%), whereas a score <2 had high sensitivity 
(94.4%) and a high negative predictive value (99.6%). In our previous reports [21], 
using a cutoff value of ≥2 points, the sensitivity of this scoring system was 54.5% 
for non-L. pneumophila serogroup 1 patients and 95.7% for L. pneumophila sero-
group 1 patients. Therefore, we could not rule out LP due to non-L. pneumophila 








Criteria for each item in the six-point scoring system.
Figure 1. 
Total scores of the six-point scoring system in Legionella pneumonia due to non-L. pneumophila serogroup 1 
and L. pneumophila serogroup 1.
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and total scores of the six-point scoring system in LP due to non-L. pneumophila 
serogroup 1 and L. pneumophila serogroup 1 are shown [21].
3. Future perspective
Patients with LP have a worse prognosis if they are not treated with appropriate 
antibiotic therapy as soon as possible. Some patients with LP due to L. pneumophila 
serogroup 1 have a negative urinary antigen test, and patients with LP due to 
non-L. pneumophila serogroup 1 are usually negative on this test. Therefore, it is 
important to suspect LP based on the clinical findings. However, as shown in our 
previous report, there are some LP patients in whom we cannot suspect LP based 
on the clinical findings specific to LP due to non-L. pneumophila serogroup 1. Thus, 
a simple method and a rapid test kit for diagnosing LP due to non-L. pneumophila 
serogroup 1 are needed.
In February 2019, Asahi Kasei Pharma Corporation released a urinary antigen 
test kit that could diagnose LP due to non-L. pneumophila serogroup 1, not only due 
to L. pneumophila serogroup 1. This kit uses an immunochromatographic method 
that has a monoclonal antibody recognizing a ribosomal protein L7/L12 unique 
region of L. pneumophila serogroups 1–15.
In the future, we expect that early diagnosis of LP including non-L. pneumophila 
serogroup 1 will be possible using this test kit.
4. Conclusion
LP due to non-L. pneumophila serogroup 1 can be a mild to severe pneumonia. 
To diagnose LP, there are some patients with LP caused by non-L. pneumophila 
serogroup 1 that could not be suspected to have LP based on their clinical findings, 
although diagnostic scoring systems have been reported to be useful for predicting 
LP. We need to investigate the usefulness of the new urinary antigen test kit that 
could theoretically diagnose these patients.
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